9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Malignant Pleural Mesothelioma

Estimated Enrollment: 30

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Recruiting

Study Results: No Results Available

Outcome Measures: Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability],  Overall survival (OS),  Disease control rate (DCR), time to progessione (TTP)

Interventions: Accelerated hypofractionation with Tomotherapy,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: July 2020

Completion Date: July 2020

Last  Posted Date: November 9, 2018

Location: SC Radiotherapy, Meldola, Italy

Website Link: https://ClinicalTrials.gov/show/NCT03269227

Was this article helpful?
Dislike 0